SHJ002 for myopia, degenerative

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 Aug 2024: Trial registered, NCT06579287
  2. 22 Jan 2025: Trial started, NCT06579287

The trials

NCT06579287: A Study of SHJ002 Sterile Ophthalmic Solution for Myopia Control

State
Under way
Phase
Phase 2
People
140 taking part
Started
22 Jan 2025
Primary completion
Dec 2026
Arms
SHJ002
Results
None posted
  1. 30 Aug 2024: Trial registered
  2. 22 Jan 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.